Actively Recruiting
Observational Study of Remote Symptom Monitoring for Patients with Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Receiving Treatment
Led by Carevive Systems, Inc. · Updated on 2026-10-30
25
Participants Needed
7
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are gathering real-world clinical and patient-reported data from cancer patients with breast, lung, ovarian, multiple myeloma, or acute myelogenous leukemia who are actively receiving treatment. This observational study aims to add to Carevives registry using an electronic care planning system that includes remote symptom monitoring, focusing on patients treatment experiences. Participants complete a baseline survey either in person with a secure device or remotely using their own electronic device. Then, they are asked to complete weekly electronic patient-reported outcome surveys via the Carevive platform for at least 12 weeks, with the option to continue these weekly surveys as long as they remain on treatment. During the study, participants provide regular symptom updates through online surveys using their phones, tablets, or computers. Researchers collect this information to create a comprehensive data set over one year. The study tracks participant responses remotely, aiming to capture ongoing treatment experiences and symptom changes without requiring in-person visits beyond the initial baseline survey.
CONDITIONS
Brief Title
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Research Team
J
JULIE SCOTT, MSN
S
Suzanne Johnson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here